UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63 | -14.9% | 4,563 | -36.5% | 0.00% | – |
Q2 2023 | $74 | +76.2% | 7,187 | +57.5% | 0.00% | – |
Q1 2023 | $42 | -100.0% | 4,563 | -14.1% | 0.00% | -100.0% |
Q1 2018 | $264,000 | -70.1% | 5,315 | -77.6% | 0.00% | -75.0% |
Q4 2017 | $884,000 | +14.1% | 23,740 | -3.5% | 0.00% | +33.3% |
Q3 2017 | $775,000 | – | 24,593 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |